Establishment Labs logo

Establishment Labs

ESTA | NASDAQ
Chart Builder DCF Calculator
$69.82
-$0.93 (-1.31%)
At close: Nov 16, 2026, 4:00 PM ET
$69.82
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.31%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
50.6
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #274/1021 (Top 27%)

Key Statistics

Market Data

Market Cap $2.08B
1D Range
68.18 70.61
52W Range
54.69 95.65

Valuation (TTM)

PE -54.55
PB 133.53
EV/EBITDA -215.88

Valuation (NTM)

Forward PE 1,061.85
Forward PEG 2.12
Price Target $95.00
Loading financial charts...

Profile

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company...

Sector Healthcare
Employees 1,004
IPO Date Jul 19, 2018
Fiscal Year January - December

Latest News

Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript

19 days ago · seekingalpha.com

Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates

19 days ago · zacks.com

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates
What Establishment Labs (ESTA) Said on Its Q3 Earnings Call

19 days ago · marketbeat.com

What Establishment Labs (ESTA) Said on Its Q3 Earnings Call
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?

26 days ago · zacks.com

Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29

29 days ago · businesswire.com

Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29

2 months ago · businesswire.com

Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
Establishment Labs: Procedure Economics Strengthens The Bull Case

2 months ago · seekingalpha.com

Establishment Labs: Procedure Economics Strengthens The Bull Case
Establishment Labs Holdings Inc. (ESTA) Q2 2026 Earnings Call Transcript

3 months ago · seekingalpha.com

Establishment Labs Holdings Inc. (ESTA) Q2 2026 Earnings Call Transcript
Establishment Labs Q2 Earnings Call Highlights

3 months ago · marketbeat.com

Establishment Labs Q2 Earnings Call Highlights
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

3 months ago · zacks.com

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

Earnings

Latest Earnings
Oct 29, 2026
EPS
-$0.35
Miss -36.28%
REV
$71.99M
Beat +7.75%
Next Earnings
Feb 23, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
8
Consensus
Buy
Price Target
$95.00
Upside
+36.06%
Buy (8)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.